On Wednesday, Following Stocks were among the “Top 50 Gainers” of U.S. Stock Market: Penn West Petroleum Ltd (USA) (NYSE:PWE), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Herbalife Ltd (NYSE:HLF), Endeavour Silver Corp (NYSE:EXK)
Penn West Petroleum Ltd (USA) (NYSE:PWE), with shares inclined 12.95%, closed at $1.57.
Amarin Corporation plc (ADR) (NASDAQ:AMRN), with shares jumped 12.66%, settled at $2.67.
Herbalife Ltd (NYSE:HLF), with shares climbed 12.58%, and closed at $38.76.
Endeavour Silver Corp (NYSE:EXK), surged 12.57%, and closed at $1.88.
Latest NEWS regarding these Stocks are depicted underneath:
Penn West Petroleum Ltd. (NYSE:PWE)
Formerly on March 12, Penn West Petroleum Ltd. (PWE), declared that it has filed with Canadian securities regulatory authorities its audited Merged Financial Statements for the year ended December 31, 2014 and related Administration’s discussion and Analysis. Penn West has also filed its Annual Information Form for the year ended December 31, 2014, which comprises the disclosure and reports regarding reserves data and other oil and gas information required following National Instrument 51-101. Penn West’s Annual Report on Form 40-F for the year ended December 31, 2014 will be filed with the U.S. Securities and Exchange Commission later that day.
Penn West Petroleum Ltd. explores for, develops, and produces oil and natural gas properties in western Canada. The corporation’s properties are located in Alberta, British Columbia, Saskatchewan, Manitoba, and the Northwest Territories, Canada.
Amarin Corporation plc (NASDAQ:AMRN)
Amarin Corporation plc (AMRN), a biopharmaceutical corporation focused on the commercialization and development of therapeutics to improve cardiovascular health, declared the presentation of findings from a new in vitro study showing that pretreatment with eicosapentaenoic acid (EPA), an omega-3 fatty acid, reduced oxidation of small dense LDL (sdLDL) and resulted in improved endothelial function when contrast to other triglyceride (TG)-lowering agents, counting fenofibrates, niacin and gemfibrozil. The research was presented recently at a peer-reviewed poster session at the American College of Cardiology Scientific Session in San Diego, California.
Researchers found that EPA pretreatment protected sdLDL particles from oxidative damage, reducing sdLDL oxidation by >90% (p<0.001) as contrast with the absence of EPA treatment. When applied directly to human umbilical vein endothelial cells (HUVECs), the vehicle-treated oxidized sdLDL significantly reduced NO release by 20% as contrast with non-oxidized sdLDL. Following exposure to sdLDL that had been treated with EPA preceding to oxidation, however, HUVEC release of NO raised significantly by 53% and 23%, as contrast with treatment with oxidized sdLDL and non-oxidized sdLDL treatments, respectively. All of the other TG-lowering agents failed to inhibit sdLDL oxidation, and instead resulted in noteworthyreductions in NO release contrast to vehicle-treated oxidized sdLDL.
Amarin Corporation plc, a biopharmaceutical corporation, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States.
Herbalife Ltd. (NYSE:HLF)
On Wednesday, Herbalife Ltd. (HLF), issued the following statement:
“Herbalife welcomes the decision by the U.S. District Court for the Central District of California to dismiss the case. As we have consistently stated, we are confident in the strong fundamentals of our business model and remain committed to assisting people and communities improve their nutrition.”
Herbalife Ltd., a nutrition corporation, develops and sells weight administration, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products. The corporation offers science-based products in four principal categories, counting weight administration; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Endeavour Silver Corp. (NYSE:EXK)
On Tuesday, Endeavour Silver Corp. (EXK), a mid-tier silver mining corporation focused on growing production, reserves and resources in Mexico, initiated a major expansion of its El Cubo mine in Guanajuato state, Mexico. The Corporation plans to ramp up mine output over the next four months from 1,550 tonnes per day (tpd), the current El Cubo plant capacity, to 2,200 tpd.
The additional 650 tpd of mine production at El Cubo will come primarily from the V-Asunción mine area, which has thicker mineralized zones amenable to long hole mining, and the Santa Cecilia mine area, which has narrower but higher grade veins, and will be processed at Endeavour’s Bolañitos plant, located 18 kilometers away in the same district, which has accessible capacity and comparable circuits to El Cubo. Production at Bolañitos will be reduced by a small amount to accommodate more processing of El Cubo ore.
The main reason for the mine expansion is to drive operating costs lower and generate free cash flow at El Cubo by taking advantage of the accessible plant capacity at Bolañitos. As a result, El Cubo will become the Corporation’s largest mine by metal production. Endeavour received the cooperation of the miners’ union at El Cubo last week in finalizing a labor contract that facilitates the mine expansion and assists establish the short- and long-term viability of the mine.
Endeavour Silver Corp. engages in the evaluation, attainment, exploration, development, and exploitation of precious metal properties in Mexico and Chile. It produces silver-gold from its underground mines. The corporation primarily holds interests in silver mining projects in Mexico comprising the Guanacevi mine in the Durango state; and the Bolañitos and El Cubo mines in the Guanajuato state.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
